{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:14:41Z","timestamp":1790640881520,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Chromatogr Sci"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1093\/chromsci\/bmw084","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T15:29:32Z","timestamp":1464017372000},"page":"1365-1372","source":"Crossref","is-referenced-by-count":19,"title":["UPLC\u2013MS-MS Method for the Determination of Vilazodone in Human Plasma: Application to a Pharmacokinetic Study"],"prefix":"10.1093","volume":"54","author":[{"given":"Ramzia","family":"El-Bagary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Tarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,21]]},"reference":[{"key":"2016090704095205000_54.8.1365.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00067.x"},{"key":"2016090704095205000_54.8.1365.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.01.018"},{"key":"2016090704095205000_54.8.1365.3","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000016"},{"key":"2016090704095205000_54.8.1365.4","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp110374"},{"key":"2016090704095205000_54.8.1365.5","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3215"},{"key":"2016090704095205000_54.8.1365.6","first-page":"28","article-title":"VilazodoneHCl (Viibryd): a serotonin partial agonist and reuptake inhibitor for the treatment of major depressive disorder","volume":"37","author":"Cruz","year":"2012","journal-title":"Pharmacy and Therapeutics"},{"key":"2016090704095205000_54.8.1365.7","unstructured":"US Food and Drug Administration . Prescribing information of VIIBRYD (Vilazodone). Forest Pharmaceuticals 2012. US Food and Drug Administration, USA."},{"key":"2016090704095205000_54.8.1365.8","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0061-5"},{"key":"2016090704095205000_54.8.1365.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2014.05.034"},{"key":"2016090704095205000_54.8.1365.10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/jat\/bku126","article-title":"A simple and fast UHPLC\u2013MS-MS assay for rapid determination of vilazodone in plasma sample","volume":"39","author":"Iqbal","year":"2014","journal-title":"Journal of Analytical Toxicology"},{"key":"2016090704095205000_54.8.1365.11","unstructured":"US DHHS, FDA and CDER. Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2001. http:\/\/www\/fda.gov\/cder\/guidance\/index.htm ."},{"key":"2016090704095205000_54.8.1365.12","first-page":"2058","article-title":"Liver microsomal metabolism of Aflatoxin B1 to a reactive derivative toxic to Salmonella typhimurium TA 1530","volume":"32","author":"Garner","year":"1972","journal-title":"Cancer Research"},{"key":"2016090704095205000_54.8.1365.13","unstructured":"Center for Drug Evaluation and Research Application Number: 022567Orig1s000. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2011\/022567Orig1s000ClinPharmR.pdf ."}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/54\/8\/1365\/7081234\/bmw084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:57:57Z","timestamp":1503565077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article-lookup\/doi\/10.1093\/chromsci\/bmw084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,21]]},"references-count":13,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,16]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1093\/chromsci\/bmw084"],"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmw084","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,21]]}}}